Table 3.

Characteristics of SLKT Recipients (Cohort 2)

Characteristic	Overall N = 5,516	Karnofsky A N = 661	Karnofsky B N = 1,999	Karnofsky C N = 2,856	p-value
Age, y, mean (SD)	55.9 (9.8)	55.7 (9.9)	56.3 (9.6)	55.7 (9.9)	0.11
Male, %	64.6	67.3	66.2	62.9	0.02
Race/ethnicity, %
White	62.9	62.9	63.4	62.6	<0.001
Black	15.2	19.4	17.4	12.8
Hispanic	16.8	11.5	15.2	19.3
Other	5.0	6.2	4.1	5.4
BMI, kg/m2, mean (SD)	27.7 (5.8)	27.4 (5.2)	27.6 (5.5)	27.9 (6.1)	0.10
Diabetes, %	42.4	39.5	45.0	41.4	0.01
Dialysis, %	69.2	58.5	63.1	76.0	<0.001
MELD score, mean (SD)	29.3 (8.1)	24.2 (6.3)	26.0 (6.8)	32.9 (7.8)	<0.001
Serum albumin, g/dL, mean (SD)	3.1 (0.8)	3.2 (0.7)	3.1 (0.7)	3.1 (0.8)	0.01
Ascites, %
Absent	17.2	30.4	21.4	11.2	<0.001
Slight	38.1	42.1	42.3	34.3
Moderate	44.1	26.2	36.1	54.0
Hepatic encephalopathy, %
None	32.1	49.3	39.3	23.1	<0.001
Grade 1–2	53.2	43.4	52.8	55.7
Grade 3–4	14.2	5.9	7.8	20.6
Medical condition, %
Not hospitalized	57.5	91.1	85.5	30.0	<0.001
Hospitalized (not ICU)	23.9	7.1	11.6	36.4
Intensive care unit	18.7	1.8	3.0	33.5
Liver disease, %
Alcohol	20.5	14.1	17.8	23.8	<0.001
Hepatitis C	22.7	23.9	24.7	21.0
Alcohol/hepatitis C	4.0	2.7	3.8	4.4
NASH/cryptogenic	21.7	17.2	20.7	23.4
Autoimmune/cholestatic	4.4	3.2	3.9	5.1
Other	26.7	38.9	29.2	22.2
Hepatocellular carcinoma, %	11.2	14.4	13.1	9.1	<0.001
Liver Donor risk index, mean (SD)	1.53 (0.30)	1.52 (0.29)	1.53 (0.32)	1.53 (0.29)	0.40
KDPI, mean (SD)	0.36 (0.26)	0.36 (0.25)	0.37 (0.26)	0.36 (0.260)	0.1516

Abbreviations:

BMI: Body mass index

MELD: Model for end-stage liver disease

ICU: Intensive care unit

NASH: Non-alcoholic steatohepatitis

KDPI: Kidney donor profile index